| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $6K | — | -22.5% |
| Cost of Revenue | $21K | — | -60.4% |
| Gross Profit | -$15K | — | +67.0% |
| R&D Expense | $0 | — | -100.0% |
| SG&A Expense | $485K | — | -71.2% |
| Operating Income | -$500K | — | +71.7% |
| Net Income | -$498K | — |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $6K | — | — |
| Inventory | $525K | -3.4% | -67.6% |
| Current Assets | $73K | +4.0% | +442.9% |
| Total Assets | $658K | -4.0% | -61.6% |
| Current Liabilities | $460K | +137.3% | +91.9% |
| Total Liabilities | $570K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$228K | — | +0.6% |
| Capital Expenditures | $0 | — | — |
| Investing Cash Flow | $0 | — | — |
| Financing Cash Flow | $210K | — | +7.0% |
| Free Cash Flow | -$228K | — | +0.6% |
| +71.8% |
| EPS (Basic) | -$0.05 | — | +70.6% |
| EPS (Diluted) | -$0.05 | — | +70.6% |
| +44.7% |
| +67.8% |
| Stockholders' Equity | $97K | -67.3% | -93.0% |